Korea’s Green Cross to Build Cell Therapy Facility in China

ChinaBio® Daily Update

Contents




Korea’s Green Cross to Build Cell Therapy Facility in China

Written by Richard Daverman, PhD, Executive Editor, Greg B. Scott.


Green Cross of South Korea will build a new cell therapy manufacturing facility in the Guian New Area of Guizhou province, located in China’s southwest corner. In South Korea, the company already produces cell therapy projects including T cell, NK cell, dendritic cell and stem cells. The new China facility will offer cellular therapeutic products for clinical studies and commercial supply, in response, the company says, to the increasing global interest in cellular therapeutic drugs as treatments for serious diseases. More details…. 

Stock Symbol: (KRX: 5280)

Share this with colleagues: 


     




More Recent Articles

Written by Richard Daverman, PhD, Executive Editor, Greg B. Scott.



Scanadu Raises $35 Million from China Investors for Mobile Diagnostic DeviceShenzhen Hepalink Pharma Enters $441 Million Deal for Resverlogix CV DrugChina Cord Blood Receives $512 Million Take-Private OfferWeek in Review: Haohai Biological Schedules $305 Million Hong Kong IPOFor Big Pharma in China, Innovation is in the Eye of the Beholder


Partner Events


Asia Biotech Invest 2015


May 19-21, 2015
Hong Kong, China



 Not a ChinaBio®Today Subscriber?

Here’s what you get with a paid subscription to ChinaBio® Today:

Website access to all current articles and commentaryFull access to over 2000 archived articles on the biotech industry


Greg B. Scott
Executive Editor
ChinaBio® Today 

ChinaBio and ChinaBio Today are trademarks of ChinaBio LLC

Related Post

Highlights on the New Findings on LRS Published in...
views 260
The article that was published in Cell is getting spotlights from other journals. So far, Molecular Cell, Science Signaling, Cell research included th...
J. Mol. Cell Biol. 발표 논문, BRIC 한빛사에 소개...
views 260
지난달  Journal of Molecular Cell Biology에 발표된 연구단 논문이 생물학연구정보센터 '한국을 빛내는 사람들(약칭 한빛사)'에 소개 되었습니다. 논문 제목은 “Splicing variant of AIMP2 as an ...
0 Comments

Leave a reply

Your email address will not be published. Required fields are marked *

*

CONTACT US

We're not around right now. But you can send us an email and we'll get back to you, asap.

Sending

©2010-2018 Medicinal Bioconvergence Research Center. All rights reserved.

Log in with your credentials

Forgot your details?

Skip to toolbar